Carregant...
Treatment of Central Precocious Puberty
Long-acting analogs of GnRH (GnRHas) have been the gold-standard treatment of central precocious puberty (CPP) worldwide and have an enviable track record of safety and efficacy. Recent years have witnessed much growth in the availability of longer-acting and sustained-release forms of GnRHas. Altho...
Guardat en:
| Publicat a: | J Endocr Soc |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Endocrine Society
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6486823/ https://ncbi.nlm.nih.gov/pubmed/31041427 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-00036 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|